Best Lymph Node Biopsy or Excision Doctors in Elmhurst, NY

We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;

We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Jeffrey Milsom, MD, FACS, has unique expertise and unparalleled experience in minimally invasive surgery for complex colorectal diseases.Dr. Milsom is the lead inventor of the endoluminal surgical platform, commercially known as the DiLumen, which stabilizes the colon to allow for endoscopic procedures of greater complexity, thereby avoiding surgery for some patients.He has performed close to 2,000 laparoscopic colon and rectal operations, and has been invited to perform surgeries in over 15 countries. Under Dr. Milsom's leadership, 90 percent of all procedures in the Colon and Rectal Section at New York Presbyterian-Weill Cornell Medical Center are now performed using high-tech, minimally invasive technologies. He has published four books, 24 book chapters and over 250 papers, presentations and educational videos.He is a member of 14 prestigious professional societies, and is a Fellow at the American Society of Colon & Rectal Surgeons, the American College of Surgeons and the Society of Surgical Oncology.After graduating summa cum laude from the University of Pennsylvania, Dr. Milsom received his medical degree from the University of Pittsburgh in 1979. He fulfilled two years of residency at Roosevelt Hospital in New York and completed his residency at the University of Virginia Medical Center, where he served as Chief Resident. He concluded his advanced training as a Fellow in Colon and Rectal Surgery at the Ferguson Clinic, Grand Rapids, Michigan in 1985, and has been a board certified colon and rectal surgeon since 1986. He joined the faculty of New York Presbyterian-Weill Cornell Medical Center in 2001.Dr. Milsom was Assistant Professor of Surgery at Michigan State University in East Lansing, Michigan from 1986 through 1989. During this period he was also the Director, Department of Surgical Research at the Ferguson Clinic. From 1990 to 1998, he was the Director of Research, Department of Colorectal Surgery at the Cleveland Clinic Foundation and from 1997 through 1998 he was also the Director of Research, Minimally Invasive Surgery Center at the Cleveland Clinic. In April 1998, Dr. Milsom became a Professor of Surgery at The Mount Sinai Medical Center in New York, Chief of the Division of Colorectal Surgery and Co-Director of Minimally Invasive Surgery.Reflecting his strong interest and expertise, Dr. Milsom currently serves as an active member of the hospital's Operating Room New Technology Committee and the Minimal Access Surgical Committee. Dr. Milsom has been recruited to participate in numerous national committees, including the Laparoendoscopic Surgical Education Committee as part of the Association of Program Directors for Colon & Rectal Surgery and the Membership Committee of the Society of American Gastrointestinal Endoscopic Surgeons.He served on the Emerging Technologies Committee for the American Society of Colon & Rectal Surgeons. Dr. Milsom is also a senior examiner for the American Board of Colon and Rectal Surgeons. He is a reviewer for Surgical Endoscopy, Diseases of the Colon & Rectum, Annals of Surgery and serves as a senior editor of WebSurg.PubMed

We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Click here to view New York Times article on Dr. Michelassi's strictureplasty for crohns disease.

It is my priority to treat every patient with a personalized and compassionate approach, while striving to offer state-of-the-art treatment options for complex endocrine and general surgical diseases. Understanding the importance of delivering thorough and timely care, I provide diagnostic services during your initial surgical consultation, including neck ultrasound, fine needle aspiration biopsy, and flexible laryngoscopy. If surgery is necessary, I offer minimally-invasive surgical approaches such as laparoscopic and robotic techniques in order to minimize post-operative pain, scarring, and length of hospitalization. Using a multidisciplinary approach to treat these complex diseases, I work closely with colleagues in endocrinology, oncology, gastroenterology, radiology, and pathology to integrate medical and surgical treatment options, as well as to orchestrate attentive long-term follow-up. Lastly, I deeply value advancing diagnostic and treatment quality for patients.

My goals are to educate you and your family about your problem and fully explain the operative and non-operative options you have to treat your condition. I am always available to my patients and our team works tirelessly to keep access and the lines of communication open. Being presented with the diagnosis of a brain tumor can be stressful, and we work hard to ensure your time with us is useful, educational, and compassionate.

I am a surgical breast oncologist and am dedicated to helping patients fight breast cancer. This effort requires a team approach involving the expertise of multiple cancer specialists as well as the perspectives of the individual patient and her/his support network. We have made exciting advances in breast cancer management resulting in successful outcomes for the majority of our patients, but ongoing progress is necessary. Working together, we can provide more options to our patients and improve access to highest-quality, personalized care throughout metropolitan New York.

Dr Tassler is a specialist in all aspects of head and neck cancer surgery His expertise lies in the diagnosis and treatment of benign and malignant tumors of the head and neck including salivary glands thyroid and parathyroid tongue lips and oral

I am a surgical breast oncologist and am dedicated to helping patients fight breast cancer. This effort requires a team approach involving the expertise of multiple cancer specialists as well as the perspectives of the individual patient and her/his support network. We have made exciting advances in breast cancer management resulting in successful outcomes for the majority of our patients, but ongoing progress is necessary. Working together, we can provide more options to our patients and improve access to highest-quality, personalized care throughout metropolitan New York.

"The Diagnosis of cancer can be overwhelming. At Cornell, we utilize a multidiciplinary team approach in the treatment of patients with lung and esophageal cancers. Our dedicated team is involved from the initial evaluation through the completion of a patient's post-operative course. This unparalleled attention to the patient helps to ease the burden of the diagnosis. For those of us involved in research as well as care, this is a very important time -- several novel treatment approaches recently have been developed here at Cornell, and we currently are showing promising results."

"What we hope to do is assemble a world class medical and research team that can provide our patients with first rate medical care and bring them the most advanced treatments."

Dr. Panagiotis Manolas, MD is a General Surgery Specialist who practices in Glendale, NY. He is 68 years old and has been practicing for 43 years. Dr. Panagiotis Manolas, MD is affiliated with Mount Sinai Queens and Mount Sinai Hospital.

Urologic oncology is a multidisciplinary field that incorporates innovative surgical technology, systemic treatments such as chemotherapy as well as a focused research effort. As a Professor of Urology and the Clinical Director of Urologic Oncology I continually interact with colleagues in areas of medical oncology, radiation oncology, pathology among others in order to provide the most comprehensive and innovative care for our patients with prostate, bladder, kidney and testicular cancer. Advances in robotic technology along with scientific progress in our precision medicine program have allowed us to direct therapy in unprecedented ways. As a leader in this area I look forward to continued advances in this exciting and challenging field.